Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 2/20 | 0.53 |
| ▸ | PRKCG | P05129 | 2/20 | 0.53 |
| ▸ | PRKCB | P05771 | 2/20 | 0.53 |
| ▸ | PRKCA | P17252 | 2/20 | 0.53 |
| ▸ | PRKCH | P24723 | 2/20 | 0.53 |
| ▸ | PRKCI | P41743 | 2/20 | 0.53 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.53 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.53 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.53 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.53 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 13/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 8/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6113854 | 0.94 | PRKD3 (0.59) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL3111012 | 0.92 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL21518914 | 0.92 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL16638072 | 0.92 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL16912929 | 0.92 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL25268261 | 0.92 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL22960177 | 0.92 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL22960173 | 0.92 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL21518916 | 0.92 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL1681846 | 0.92 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109535121-A | A method of preparing 2- methyl -2- isobutyl group -4- methylol -1,3-dioxolane | 江苏天音化工有限公司 | 2019-03-29 | — | — | CN | disclosed |
| CN-109503541-A | A kind of preparation method of 2- methyl -2- isobutyl group -4- methylol -1,3-dioxolane | 江苏天音化工有限公司 | 2019-03-22 | — | — | CN | disclosed |
| WO-2011106194-A2 | PROCESS FOR MAKING POLYOL ETHERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-09-01 | — | — | WO | disclosed |
| US-20110207969-A1 | PROCESS FOR MAKING POLYOL ETHERS | DOW GLOBAL TECHNOLOGIES LLC | 2011-08-25 | — | — | US | disclosed |
| US-20110207969-A1 | PROCESS FOR MAKING POLYOL ETHERS | DOW GLOBAL TECHNOLOGIES LLC | 2011-08-25 | — | — | US | disclosed |
| US-20080280997-A1 | Novel Pharmaceutical or Cosmetic Carriers Containing Cyclic Acetals | GATTEFOSSE SAS (FR) | 2008-11-13 | — | — | US | disclosed |
| EP-1737495-A1 | NOVEL PHARMACEUTICAL OR COSMETIC CARRIERS CONTAINING CYLCIC ACETALS | GATTEFOSSE SAS (FR) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005105149-A1 | NOVEL PHARMACEUTICAL OR COSMETIC CARRIERS CONTAINING CYLCIC ACETALS | GATTEFOSSE SAS (FR) | 2005-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207969-A1 | PROCESS FOR MAKING POLYOL ETHERS | PUF60, PARG, PCBP1 | PRKD3 3103/4885PRKCG 1984/4885PRKCB 3213/4885 |
| US-20080280997-A1 | Novel Pharmaceutical or Cosmetic Carriers Containing Cyclic Acetals | ACAT2, ACACB, ACAT1 | PRKD3 2528/4885PRKCG 2467/4885PRKCB 1518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.